The Importance of Bone Marrow Lymphocyte Subtypes As Predicting Factors for Molecular Recurrence in Patients with Chronic Myeloid Leukemia after Discontinuation of Imatinib

被引：0

作者：

Oliveira Braga, Arthur Gomes ^{[1
,2
]}

Pagnano, Katia B. ^{[1
]}

Pelegrini Campioni, Marina Dal'Bo ^{[3
]}

Lopez, Ana Beatriz P. ^{[1
]}

Metze, Konradin ^{[4
]}

Duarte, Gislaine B. O. ^{[1
]}

Lorand-Metze, Irene ^{[5
]}

机构：

[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, Brazil

[2] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Paulinia, Brazil

[3] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Campinas, Brazil

[4] Univ Estadual Campinas, Dept Pathol, Fac Med, Campinas, Brazil

[5] Univ Estadual Campinas, Dept Internal Med, Fac Med, Campinas, Brazil

来源：

关键词：

chronic myeloid leukemia; imatinib; discontinuation; lymphocytes; pioglitazone;

D O I：

10.1182/blood-2021-149242

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2564

引用

页数：3